FGEN Fibrogen Inc

FibroGen Inc is a biopharmaceutical company. It is engaged in the discovery, development and commercialization of novel therapeutics to treat serious unmet medical needs.

$18.61  -0.20 (-1.06%)
As of 04/09/2021 15:59:59 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  11/14/2014
Outstanding shares:  91,560,468
Average volume:  2,412,613
Market cap:   $1,700,277,891
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    31572Q808
ISIN:        US31572Q8087
Sedol:      BSDRYR8
Valuation   (See tab for details)
PE ratio:   -8.98
PB ratio:   4.02
PS ratio:   9.64
Return on equity:   -44.84%
Net income %:   -107.36%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy